IRIS
CAIAFFA, MARIA FILOMENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.835
AS - Asia 1.008
EU - Europa 993
SA - Sud America 221
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.118
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.794
SG - Singapore 395
CN - Cina 287
DE - Germania 238
BR - Brasile 175
IT - Italia 168
RU - Federazione Russa 165
SE - Svezia 165
HK - Hong Kong 91
GB - Regno Unito 75
VN - Vietnam 69
FR - Francia 59
IN - India 44
FI - Finlandia 39
CI - Costa d'Avorio 28
PL - Polonia 20
BD - Bangladesh 18
MX - Messico 17
CA - Canada 16
TR - Turchia 15
IQ - Iraq 14
ID - Indonesia 13
AR - Argentina 11
CO - Colombia 10
ES - Italia 10
JP - Giappone 10
PK - Pakistan 10
RS - Serbia 9
ZA - Sudafrica 9
EC - Ecuador 8
NL - Olanda 8
BE - Belgio 7
CL - Cile 6
LT - Lituania 6
MA - Marocco 6
AT - Austria 5
JO - Giordania 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
MY - Malesia 4
PH - Filippine 4
SA - Arabia Saudita 4
TN - Tunisia 4
CZ - Repubblica Ceca 3
IE - Irlanda 3
KE - Kenya 3
PY - Paraguay 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
CH - Svizzera 2
CR - Costa Rica 2
EU - Europa 2
HU - Ungheria 2
IL - Israele 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
IM - Isola di Man 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MW - Malawi 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
SR - Suriname 1
TJ - Tagikistan 1
TW - Taiwan 1
UA - Ucraina 1
UG - Uganda 1
ZM - Zambia 1
Totale 4.118
Salva come PNG Salva come JPEG
Città #
Ashburn 328
Singapore 233
Chandler 155
San Jose 138
Nyköping 127
Beijing 103
Fairfield 91
Hong Kong 91
New York 74
Munich 54
Houston 52
Dallas 51
Cambridge 45
Dearborn 44
Seattle 43
Los Angeles 38
Woodbridge 36
Nanjing 35
Bari 34
Brooklyn 32
Lawrence 31
Roxbury 29
Wilmington 29
Abidjan 28
Lauterbourg 28
Helsinki 25
Des Moines 23
Ho Chi Minh City 22
Redwood City 21
São Paulo 21
Ann Arbor 20
Buffalo 15
Frankfurt am Main 14
Hanoi 14
Chennai 13
Santa Clara 13
Turku 13
Boardman 12
Orem 12
Shenyang 12
Warsaw 12
Basingstoke 10
Denver 10
Nanchang 10
Tokyo 10
Belgrade 9
Falkenstein 8
Inglewood 8
Milan 8
Rome 8
San Francisco 8
Boston 7
Brussels 7
Jinan 7
Mumbai 7
San Diego 7
Ankara 6
Atlanta 6
Baghdad 6
Changsha 6
Guangzhou 6
Johannesburg 6
London 6
Moscow 6
Phoenix 6
Amman 5
Belo Horizonte 5
Chicago 5
Columbus 5
Haiphong 5
Hebei 5
Montreal 5
New Delhi 5
Paris 5
Poplar 5
Brasília 4
Council Bluffs 4
Fortaleza 4
Hefei 4
Jiaxing 4
Karachi 4
Kunming 4
Medellín 4
Princeton 4
Pune 4
Querétaro 4
Quito 4
Stockholm 4
Tashkent 4
The Dalles 4
Ancona 3
Bitonto 3
Bolzano 3
Campinas 3
Caxias do Sul 3
Chieti 3
Dublin 3
Guayaquil 3
Hangzhou 3
Jacksonville 3
Totale 2.529
Salva come PNG Salva come JPEG
Nome #
A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy 174
Cost-effectiveness of grass pollen allergen immunotherapy in adults 153
Wasp immunotherapy induced long-term and IgG4-independent protection 152
L'allergia alimentare della Dieta Mediterranea 148
Allergia al latte. Studio sulla risposta IgE-mediata in vivo verso frazioni proteiche di latte di capra Garganica 142
Test di proliferazione linfocitaria nella diagnosi delle reazioni ritardate a farmaci 135
Studi su Omalizumab nella terapia dell'asma severo. Valutazione degli effetti sulla risposta immunologica IgE in vivo. Valutazione della tollerabilità. 132
Desensitization in Iron Product Allergy 128
Omalizumab in long-term treatment of refractory chronic spontaneus urticaria:effects of discontinuation 125
Terapia dell'asma severo con omalizumab: uno studio real life in 51 pazienti. 124
Omalizumab nel trattamento dell'allergia alimentare 124
Leukotriene biosynthesis inhibition and direct 5-lipoxygenase (5-LO) non competitive inhibition by the Cys-LT1 receptor antagonists montelukast 122
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort 121
Fennel (Phoeniculum vulgare): a major allergen of the Mediterranean Diet 117
Fennel (Foeniculum vulgare) allergy. 110
Composizione pollinica dell'atmosfera di Barletta 109
Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases 107
Novel inhibitory effect on 5-lipoxygenase by the anti-asthma drug montelukast 105
Omalizumab nell'orticaria cronica spontanea: uno studio real-life su 14 pazienti 105
A desensitization protocol for delayed allergy to cytarabine: Analysis of two cases 100
The lymphocyte proliferation test (LPT) in the diagnosis of critical cases of delayed drug allergy. 99
La disfunzione psicosomatica delle corde vocali 99
Planned omalizumab discontinuation in CSU management as a sustainable strategy: A 2-year real-life study 97
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 89
Five-lipoxygenase/leukotriene pathway inhibition by caffeic acid phenetyl ester, caffeic acid and chlorogenic acid, natural products with anti-oxidant and anti-inflammatory properties 89
Importance of Specific IgE/Total IgE Ratio in Disambiguating Amoxicillin Allergy Diagnosis in a Real-Life Setting 89
Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS) 88
Sensitivity and specificity of new Vespa crabro allergen extract in patients with anaphylaxis to V. crabro. 87
Efficacy and safety of allergen immunotherapy in patients with allergy to molds: A systematic review 87
Safety of measles, mumps, and rubella vaccine in egg allergy: in vivo and in vitro management 86
Duration of chronic spontaneous urticaria remission after omalizumab discontinuation: A long-term observational study 81
Long-term treatment of refractory severe urticaria by omalizumab: analysis of two cases. 76
Rapid desensitization for brentuximab vedotin (Adceteris®) allergy: A case report 75
Recognition of novel Mediterranean food allergens:allergy to artichoke 74
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission 73
null 72
null 71
null 68
null 64
null 60
SANI-Severe Asthma Network in Italy: A way forward to monitor severe asthma 39
Totale 4.196
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.108
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 0 19 11 15
2021/2022250 5 22 3 3 9 32 8 13 5 14 37 99
2022/2023425 44 98 36 12 30 60 7 29 86 1 14 8
2023/2024262 10 28 12 15 11 111 30 21 2 2 2 18
2024/2025759 46 4 70 11 12 68 80 72 27 46 128 195
2025/20261.591 263 112 108 188 264 93 179 45 177 162 0 0
Totale 4.196